Skip to main content
Fig. 6 | Cancer Imaging

Fig. 6

From: Intratumoral and peritumoral CT radiomics in predicting anaplastic lymphoma kinase mutations and survival in patients with lung adenocarcinoma: a multicenter study

Fig. 6

Individualized prognostic stratification of the prediction score of the combined model in ALK (+) patients undergoing ALK-TKI therapy and ALK (-) patients receiving immunotherapy. The correlation between the prediction score and the progression-free survival time in the ALK-TKI therapy group (A) and immunotherapy group (B). The progression-free survival stratification of the model prediction score in the ALK-TKI therapy group (C) and immunotherapy group (D). ALK, anaplastic lymphoma kinase; HR, hazard ratio; TKI, tyrosine kinase inhibitor

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us